目前对口腔膜状细胞癌的治疗方法以及向分子治疗的转变
Mitra Elmi1,2, Joshua H Dass1,3, Crispin R Dass1,2
1Curtin Medical School, Curtin University, Perth, WA, Australia.
The Journal of pharmacy and pharmacology
|August 13, 2024
概括
放射治疗是口腔状细胞癌 (OPSCC) 的主要治疗方法,这是头癌的一个子集. 分子疗法正在出现,但主要是在临床前阶段.
科学领域:
- 在瘤学瘤学.
- 头部和部癌症研究研究
- 分子医学是分子医学.
背景情况:
- 口腔状细胞癌 (OPSCC) 是头部和部状细胞癌 (HNSCC) 的一个重要子集.
- 对OPSCC的治疗策略范围从激进的治疗意图到息性疾病控制.
- 了解OPSCC的分子机制对于推进治疗模式至关重要.
研究的目的:
- 审查口腔状细胞癌 (OPSCC) 的当前治疗选择.
- 专注于在头癌的更广泛背景下推动OPSCC的分子机制.
- 提供OPSCC管理的最新进展和未来方向的概述.
主要方法:
- 对OPSCC目前常规治疗方式的审查.
- 检查最近的进展和新兴的治疗策略.
- 对OPSCC发展和进展的分子基础的分析.
主要成果:
- 放射治疗是全球OPSCC的主要治疗方式,包括在澳大利亚,美国,英国和新西兰.
- 外科手术通常用于表面的OPSCC或部剖析,通常随后是放射治疗.
- 目前的分子疗法主要处于临床前开发阶段.
结论:
- 虽然放射治疗仍然是OPSCC治疗的基石,但分子疗法显示出希望.
- 临床试验目前正在评估向药物,如 cetuximab,nivolumab,pembrolizumab,Lenvatinib 和 bevacizumab.
- 对分子机制的进一步研究对于开发OPSCC有效的向治疗是必不可少的.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.0K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
